Revenues in USD of Ernexa Therapeutics Inc. from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Ernexa Therapeutics Inc. quarterly/annual Revenues history and change rate from Q2 2011 to Q4 2024.
  • Ernexa Therapeutics Inc. Revenues for the quarter ending December 31, 2024 was $1K.
  • Ernexa Therapeutics Inc. Revenues for the twelve months ending December 31, 2024 was $582K.
  • Ernexa Therapeutics Inc. annual Revenues for 2024 was $582K, a 756% increase from 2023.
  • Ernexa Therapeutics Inc. annual Revenues for 2023 was $68K.
  • Ernexa Therapeutics Inc. annual Revenues for 2022 was $0.000.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Ernexa Therapeutics Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $582K $1K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-12
Q3 2024 $487K +$436K +855% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 $47K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $47K +$47K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q3 2023 $51K +$51K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q1 2019 $4.83M -$929K -16.1% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
Q1 2018 $21.8M $5.76M +$530K +10.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $21.3M $5.3M -$684K -11.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 $22M $5.2M -$245K -4.5% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $22.2M $5.55M +$142K +2.63% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $22.1M $5.23M -$251K -4.58% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $22.3M $5.98M -$541K -8.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $22.9M $5.44M -$636K -10.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $23.5M $5.41M -$786K -12.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $24.3M $5.48M -$244K -4.26% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $24.5M $6.52M -$229K -3.39% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 $24.7M $6.08M +$74K +1.23% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $24.7M $6.19M -$680K -9.89% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $25.4M $5.73M -$692K -10.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $26M $6.75M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $6.01M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $6.87M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $6.42M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q2 2012 $6.02M -$55K -0.91% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-14
Q2 2011 $6.07M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14

Ernexa Therapeutics Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $582K +$514K +756% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-12
2023 $68K +$68K Jan 1, 2023 Dec 31, 2023 10-K 2025-03-12
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2020 $5.8M -$14M -70.7% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-11
2019 $19.8M -$3.53M -15.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $23.3M +$2.06M +9.69% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 $21.3M -$1.04M -4.65% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $22.3M -$2.21M -9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 $24.5M -$1.53M -5.86% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-09
2014 $26M +$2.3M +9.67% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $23.7M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.